19 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26710088	248	Recent Progress in Histone Demethylase Inhibitors.	University of Oxford
26699912	108	Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.	University of Oxford
26741168	239	8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.	The Institute of Cancer Research
23964788	56	Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.	Kyoto Prefectural University of Medicine
23725560	22	Quantitative analysis of histone demethylase probes using fluorescence polarization.	University of Colorado
22724510	84	Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.	University of Oxford
21955276	60	Lysine demethylases inhibitors.	Kyoto Prefectural University of Medicine
32551003	53	Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors.	Constellation Pharmaceuticals
30745098	24	Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.	Kyoto Prefectural University of Medicine
31158747	257	C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.	Institute of Cancer Research
26682034	229	Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.	University of Oxford
24325601	74	Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.	Sapienza University of Rome
29627262	109	Structure-based design and discovery of potent and selective KDM5 inhibitors.	Celgene
28160945	12	In search of new a-glucosidase inhibitors: Imidazolylpyrazole derivatives.	University of The Punjab
19217287	30	Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.	Abbott Laboratories
12419810	6	Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.	University of Padova